<DOC>
	<DOCNO>NCT00897546</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample blood patient cancer study laboratory may help doctor learn change may occur DNA identify biomarkers related cancer , may help doctor learn well patient respond treatment . PURPOSE : This laboratory study look biomarkers predict response interferon therapy patient melanoma .</brief_summary>
	<brief_title>Biomarkers Predict Response Interferon Therapy Patients With Melanoma</brief_title>
	<detailed_description>OBJECTIVES : - Generate comprehensive multiplexed array melanoma-associated serological marker validate use serum sample patient melanoma healthy control participant . - Determine change profile serological marker induce interferon-alfa 2b ( IFN-α2b ) therapy . - Define panel serological marker prognostic predictive power IFN-α2b therapy responses patient melanoma . OUTLINE : This multicenter study . Serum sample use multiplex analysis . Biomarkers assess include cytokine , chemokines , growth factor , angiogenic antiangiogenic molecule , matrix metalloproteases ( MMPs ) , tissue inhibitor MMPs ( TIMPs ) , melanoma-associated antigen , basic fibroblast growth factor , insulin-like growth factor I II , thrombospondin , endostatin , angiostatin , vasostatin , vascular endothelial growth factor inhibitor . PROJECTED ACCRUAL : A total 1,716 sample accrue study .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis melanoma OR healthy volunteer ( control ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>recurrent melanoma</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>stage IA melanoma</keyword>
	<keyword>stage IB melanoma</keyword>
	<keyword>stage IIA melanoma</keyword>
	<keyword>stage IIB melanoma</keyword>
	<keyword>stage IIC melanoma</keyword>
	<keyword>stage IIIA melanoma</keyword>
	<keyword>stage IIIB melanoma</keyword>
	<keyword>stage IIIC melanoma</keyword>
</DOC>